Academic Groups Recognized for Drug Delivery Papers

Article

The Catalent Applied Drug Delivery Institute and AAPS recognize four groups for emerging scientific talent and academic excellence.

The Catalent Applied Drug Delivery Institute and the American Association of Pharmaceutical Scientists (AAPS) have announced winners of the Global Academic Competition for Life Science Leaders of Tomorrow, a competition that identifies emerging scientific talent, fosters drug delivery education, and rewards academic excellence.

The four winning entries, chosen from US and European universities with graduate programs in pharmaceutical science, each receive $2,000, a complimentary, one-year membership to the AAPS, and the potential opportunity to have their review published in a peer-reviewed journal.

The 2015 winners are:

  • Marius Hittinger and Nicole Schneider-Daum from Helmholtz-Institute for Pharmaceutical Research Saarland, Germany, for their submission “Cell And Tissue-Based in vitro Improving the Development of Oral Inhalation Drug Products”;

  • Mania Dorrani and Bozena Michniak-Kohn of Rutgers University for “Topical siRNA Delivery: Challenges and Prospects”;

  • Harini Venkata Krishnan and Shilpa Sant from University of Pittsburgh for “Three Dimensional Cell Cultures: Opportunities for Drug Discovery and Development” and;

  • Zhijian He, Daria Alakhova, Alexander V. Kabanov University of North Carolina at Chapel Hill for “Nanoformulations of Taxanes.”

“Our goal, for the competition, and for the Institute itself, is to foster education, collaboration and adoption of innovative drug delivery technologies to develop better treatments for patients,” commented Sharon Johnson, Catalent’s Senior VP, Quality, Product Development & Regulatory Affairs in a press statement. “The standard of entries in this year’s competition was exceptional. We congratulate all the winners and look forward to sharing their reviews with the wider drug delivery community.”

Source: Catalent Drug Delivery Institute

 

 

 

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content